Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 19, 2019 at 04:13 pm
Share
Manhattan Scientifics, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was USD 22,000 compared to USD 0 a year ago. Operating loss was USD 168,000 compared to USD 322,000 a year ago. Net income was USD 1.229 million compared to USD 324,000 a year ago. For the nine months, sales was USD 72,000 compared to USD 0 a year ago. Operating loss was USD 879,000 compared to USD 1.990 million a year ago. Net loss was USD 115,000 compared to USD 4.717 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
MANHATTAN SCIENTIFICS, INC. 
